MetaCap

Scienture (SCNX) vs Silo Pharma (SILO)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Scienture is the larger company by market cap ($4.1 million vs $3.7 million), about 1.1 times the size. Silo Pharma converts more of its revenue into profit, with a net margin of -5863.5% versus -9618.0%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

SCNX-44.85%SILO+18.75%
+37%-6%-49%
Oct 7, 20261 yearNov 20, 2026
SCNX-39.42%SILO+16.33%
+28%-7%-43%
Oct 5, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

SCNX versus SILO key metrics
MetricSCNXSILO
Share price$2.28$1.71
Market cap$4.07M$3.69M
1-day change-6.45%-9.04%
EPS (TTM)$-51.70$-2.26
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$431.61K$72.10K
Revenue growth (YoY)+215.87%0.00%
Net income (latest FY)$-41.51M$-4.23M
Gross margin76.80%38.57%
Operating margin-9867.92%-5936.95%
Net margin-9618.03%-5863.50%
52-week high$18.75$10.43
52-week low$2.00$1.10
Distance from 52-week high-87.85%-83.60%
Analyst consensusbuy—
Avg. price target upside+1546.25%—
Average volume156.51K65.47K
Shares outstanding1.79M2.16M
Employees43
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Silo Pharma is more profitable, keeping -5863.5 cents of every revenue dollar as net income versus -9618.0 cents for Scienture.
  • Scienture grew revenue faster in its latest fiscal year (+215.87% vs 0.00%).

About Scienture

SCNX stock →

Scienture Holdings, Inc. operates as pharmaceutical company that focuses on development and commercialization of products for the treatment of central nervous system and cardiovascular diseases in the United States.

Health Care · Biotechnology: Pharmaceutical Preparations · 4 employees

About Silo Pharma

SILO stock →

Silo Pharma, Inc. operates as a developmental stage biopharmaceutical company.

Health Care · Biotechnology: Pharmaceutical Preparations · 3 employees

SCNX vs SILO FAQ

Which is bigger, Scienture or Silo Pharma?

Scienture (SCNX) is larger, with a market capitalization of $4.07M compared with $3.69M for Silo Pharma (SILO).

Are Scienture and Silo Pharma in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons